BiotechTube

mycophenolate mofetil [CellCept]

ApprovedTerminated
0 watching 0 views this week🔥 Hot
85
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Kidney Transplantation

Conditions

Kidney Transplantation

Trial Timeline

Mar 1, 2007 → —

NCT ID
NCT00420472

About mycophenolate mofetil [CellCept]

mycophenolate mofetil [CellCept] is a approved stage product being developed by Roche for Kidney Transplantation. The current trial status is terminated. This product is registered under clinical trial identifier NCT00420472. Target conditions include Kidney Transplantation.

Hype Score Breakdown

Clinical
30
Activity
20
Company
10
Novelty
10
Community
12

Clinical Trials (2)

NCT IDPhaseStatus
NCT00420472ApprovedTerminated
NCT00121784ApprovedTerminated

Competing Products

20 competing products in Kidney Transplantation

See all competitors
ProductCompanyStageHype Score
Empagliflozin + Matching placeboEli LillyPhase 3
77
Baricitinib + PlaceboEli LillyPhase 2
52
SGLT2 inhibitorEli LillyPre-clinical
23
LY2623091 + EplerenoneEli LillyPhase 2
52
Telmisartan/Rosuvastatin 40/10mg + Telmisartan 40mgYuhanApproved
85
TacrolimusAstellas PharmaApproved
85
RituximabAstellas PharmaPhase 2
52
Prograf + MR4Astellas PharmaPhase 3
77
basiliximab + rabbit anti-thymocyte globulin + tacrolimus + alemtuzumab + mycophenolate mofetil + steroidsAstellas PharmaApproved
85
Tacrolimus, modified releaseAstellas PharmaPhase 3
77
Tacrolimus granulesAstellas PharmaApproved
85
roxadustatAstellas PharmaPhase 3
77
Tacrolimus immediate-release formulation + Tacrolimus prolonged-release formulation + Induction therapy + Mycophenolic acid drugs + CorticosteroidsAstellas PharmaApproved
85
ASP1128 + PlaceboAstellas PharmaPhase 2
52
FK506MR + Prograf + Mycophenolate Mofetil + Methylprednisolone + PrednisoloneAstellas PharmaPhase 3
77
MMF (Cellcept) and Steroids + Tacrolimus (Prograf)Astellas PharmaApproved
85
ASP1585Astellas PharmaPhase 3
77
Alefacept + tacrolimus + basiliximab + mycophenolate mofetil + CorticosteroidsAstellas PharmaPhase 2
52
Advagraf + Mycophenolate Mofetil + Simulect + CorticosteroidsAstellas PharmaApproved
85
tacrolimusAstellas PharmaApproved
85

Other Products from Roche

EmicizumabApproved
85
rituximab + methotrexate + methylprednisolone + acetaminophen + antihistamineApproved
85
RituximabApproved
85
saquinavir/ritonavir + atazanavir/ritonavirApproved
85
5-FU based doublet chemotherapy + bevacizumabApproved
85